Although clinicopathological parameters, such as risk classification and tumor stage, may be closely associated with the early biochemical recurrence of PCa (28), studies concerning the potential roles of MT-2A and cyclin E in predicting biochemical recurrence of PCa are limited. Here, MT2A is linked to posterior cortical atrophy.